EBS - Emergent BioSolutions secures $250M contracts for the U.S. government
2024-07-02 08:31:31 ET
More on Emergent Biosolutions
- Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround
- Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript
- Emergent BioSolutions Inc. 2024 Q1 - Results - Earnings Call Presentation
- Emergent to sell Baltimore-Camden production site for $30M
- Walgreens launches its own opioid reversal therapy for OTC use